Peng, L. (2025) “Effects of monoclonal antibody daratumumab combined with ixazomib-based treatment regimen on survival of patients with relapsed/refractory multiple myeloma”, Vojnosanitetski pregled, 82(04). doi:10.2298/VSP231207016P.